A plasmid construct encoding murine interferon beta antagonizes the replication of herpes simplex virus type I in vitro and in vivo

Journal of Neuroimmunology

Volumn 108, Issue 1-2, 2000, Pages 92-102

  Cui, Bo ^a   Carr, Daniel J J ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Gene therapy; HSV 1; Interferon

Indexed keywords

ANTIVIRUS AGENT; BETA INTERFERON; PLASMID DNA; RECOMBINANT BETA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE THERAPY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; INFECTION RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CORNEA; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; INTERFERON-BETA; MICE; MICE, INBRED ICR; PLASMIDS; SURVIVAL RATE; TRANSFECTION; TRANSGENES; TRIGEMINAL GANGLION; VACCINES, DNA; VIRAL LOAD; VIRUS REPLICATION;

EID: 0034255727     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00264-2     Document Type: Article

References (44)

1. Bartholome, E.J., Willems, F., Crusiaux, A., Thielemans, K., Schandene, L., Goldman, M., 1999. IFN-β interferes with the differentiation of dendritic cells from peripheral blood mononuclear cells: selective inhibition of CD40-dependent interleukin-12 secretion. J. Interferon Cytokine Res. 19, 471-478.
2. Belardelli, F., Gresser, I., 1996. The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunol. Today 17, 369-372.
3. Carr, D.J.J., 1998. Increased levels of IFN-γ in the trigeminal ganglion correlate with protection against HSV-1-induced encephalitis following subcutaneous administration of androstenediol. J. Neuroimmunol. 89, 160-167.
4. Carr, D.J.J., Veress, L.A., Noisakran, S., Campbell, I.L., 1999. Astrocyte-targeted expression of IFN-α1 protects mice from acute ocular herpes simplex virus type 1 infection. J. Immunol. 161, 4859-4865.
5. Chatterjee, S., Hunter, E., Whitley, R., 1985. Effect of cloned interferons on protein synthesis and morphogenesis of herpes simplex virus. J. Virol. 56, 419-425.
6. Chen, C., Okayama, H., 1987. High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752.
7. Corey, L., Spear, P.G., 1986a. Infections with herpes simplex viruses (1). New Engl. J. Med. 314, 486-691.
8. Corey, L., Spear, P.G., 1986b. Infections with herpes simplex viruses (2). New Engl. J. Med. 314, 749-757.
9. Dahesia, M., Kuklin, N., Manickan, E., Chun, S., Rouse, B.T., 1998. Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines. Vaccines 16, 1103-1110.
10. Dean, D.A., Byrd, J.N., Dean, B.S., 1999. Nuclear targeting of plasmid DNA in human corneal cells. Curr. Eye Res. 19, 66-75.
11. Gresser, I., Tovey, M.G., Maury, C., Bandu, M.-T., 1976. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. J. Exp. Med. 144, 1316-1323.
12. Grumbach, I.M., Fish, E.N., Uddin, S., Majchrzak, B., Colamonici, O.R., Figulla, H.R., Heim, A., Platanias, L.C., 1999. Activation of the Jak-Stat pathway in cells that exhibit selective sensitivity to the antiviral effects of IFN-β compared with IFN-α. J. Interferon Cytokine Res. 19, 797-801.
13. Halford, W.P., Gebbhardt, B.M., Carr, D.J.J., 1996. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type I. J. Immunol. 157, 3542-3549.
14. Hayden, F.G., 1996. Antimicrobial agents: antiviral agents. In: Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., Gilman, A.G. (Eds.), Goodman & Gilman's the Pharmacological Basis of Therapeutics, 9th Edition. McGraw-Hill, New York, pp. 1211-1214.
15. Herpectic Eye Disease Study Group, 1998. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. New Engl. J. Med. 339, 300-306.
16. Hwang, S.Y., Hertzog, P.J., Holland, K.A., Sumarsono, S.H., Tymms, M.J., Hamilton, J.A., Whitty, G., Bertoncello, I., Kola, I., 1995. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons α and β and alters macrophage responses. Proc. Natl. Acad. Sci. USA 92, 11284-11288.
17. Jakob, T., Walker, P.S., Krieg, A.M., Udey, M.C., Vogel, J.C., 1998. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161, 3042-3049.
18. Johnson, H.M., 1981. Cellular recognition of immune interferon production. Antiviral Res. 1, 37.
19. Klinman, D.M., Yi, A.K., Becaucage, S.L., Conover, J., Krieg, A.M., 1996. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. USA 93, 2879-2883.
20. Leib, D.A., Harrison, T.E., Laslo, K.M., Machalek, M.A., Moorman, N.J., Virgin, H.W., 1999. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189, 663-672.
21. Liesegang, T.J., Melton, III L.J., Daly, P.J., Illstrup, D.M., 1989. Epidemiology of ocular herpes simplex: incidence in Rochester, Minn, 1950 through 1982. Arch. Ophthalmol. 107, 1155-1159.
22. Lopez-Callazo, E., Hortelanol, S., Rojas, A., Bosca, L., 1998. Triggering of peritoneal macrophages with IFN-α/β attenuates the expression of inducible nitric oxide synthase through a decrease in NF-κB activation. J. Immunol. 160, 2889-2895.
23. Mahalingam, S., Farber, J.M., Karupiah, G., 1999. The interferon-inducible chemokines MuMig and CRG-2 exhibit antiviral activity in vivo. J. Virol. 73, 1479-1491.
24. McDonnell, W.M., Askan, F.K., 1996. DNA vaccines. New Engl. J. Med. 334, 42-45.
25. Minagawa, H., Sakai, Y., Li, Y.-Y., Ishibashi, T., Inomata, H., Mori, R., 1997. Suppression of infectious virus spread and corneal opacification by the combined use of recombinant interferon beta and interleukin-10 following corneal infection with herpes simplex virus-1 in mice. Antiviral Res. 36, 99-105.
26. Munoz, A., Carrasco, L., 1984. Formation of non-infective herpesvirus particles in cultured cells treated with human interferon. J. Gen. Virol. 65, 1069-1078.
27. Newell, C., Martin, K.S., Sendele, D., Mercadal, C.M., Rouse, B.T., 1989. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J. Virol. 63, 769-775.
28. Niemialtowski, M.G., Rouse, B.T., 1992. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J. Immunol. 149, 3035-3039.
29. Noisakran, S., Campbell, I.L., Carr, D.J.J., 1999. Ectopic expression of DNA encoding IFN-1 in the cornea protects mice from herpes simplex virus type I-1 induced encephalitis. J. Immunol. 162, 4184-4190.
30. Noisakran, S., Campbell, I.L., Carr, D.J.J., 2000. IFN-α1 plasmid construct affords protection against HSV-1 infection in transfected L929 fibroblasts. J. Interferon Cytokine Res. 20, 107-115.
31. Pepose, J.S., Leib, D.A., Stuart, P.M., Easty, D.L., 1996. Herpes simplex virus diseases: anterior segment of the eye. In: Pepose, J.S., Holland, G.N., Wilhelmus, K.R. (Eds.), Ocular Infection and Immunity. Mosby, St. Louis, pp. 905-932.
32. Rogers, B.B., Josephson, S.L., Mak, S.K., 1991. Detection of herpes simplex virus using the polymerase chain reaction followed by endonuclease cleavage. Am. J. Pathol. 139, 1-6.
33. Roman, M., Martin-Orozco, E., Goodman, J.S., Nguyen, M.D., Sato, Y., Ronaghy, A., Kombluth, R.S., Richman, D.D., Carson, D.A., Raz, E., 1997. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3, 849-854.
34. + αβ T cells. Invest. Ophthalmol. Vis. Sci. 41, 138-144.
35. Sambrook, J., Fritsch, E.F., Maniatis, T., 1989. In: Nolan, C. (Ed.), 2nd Edition. Molecular Cloning: A Laboratory Manual, Vol. 1. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, p. 1.33.
36. Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M.-D., Silverman, G.J., Lotz, M., Carson, D.A., Raz, E., 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352-354.
37. Sciammas, R., Johnson, R.M., Sperling, A.I., Brady, W., Linsley, P.S., Spear, P.G., Fitch, F.W., Bluestone, J.A., 1994. Unique antigen recognition by a herpesvirus-specific TCR-γδ cell. J. Immunol. 152, 5392-5397.
38. Sciammas, R., Kodukula, P., Tang, Q., Hendricks, R.L., Bluestone, J.A., 1997. T cell receptor-γ/δ cells protect mice from herpes simplex virus type 1-induced lethal encephalitis. J. Exp. Med. 185, 1969-1975.
39. Tighe, H., Corr, M., Roman, M., Raz, E., 1998. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol. Today 19, 89-97.
40. Triantaphyllopoulos, K.A., Croxford, J.L., Baker, D., Chernajovsky, Y., 1998. Cloning and expression of murine IFN β and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis. Gene Ther. 5, 253-263.
41. Tumpey, T.M., Chen, S.H., Oakes, J.E., Lausch, R.N., 1996. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70, 898-904.
42. Vodjdani, G., Coulombel, C., Doly, J., 1988. Structure and characterization of a murine chromosomal fragment containing the interferon β gene. J. Mol. Biol. 204, 221-231.
43. Ward, L.A., Massa, P.T., 1995. Neuron-specific regulation of major histocompatability complex class I interferon-β, and anti-viral state genes. J. Neuroimmunol. 58, 145-155.
44. Wilhelmus, K.R., Coster, D.J., Donovan, H.C., Falcon, M.G., Jones, B.R., 1981. Prognosis indicators of herpetic keratitis: analysis of a 5-year observation period after corneal ulceration. Arch. Ophthalmol. 99, 1578-1582.